News

The dual orexin receptor antagonist notably demonstrates a positive benefit-risk balance for patients

The skin graft is produced from 2 types of human skin cells, keratinocytes and dermal fibroblasts.

California has administered more than 40 million doses of the COVID-19 vaccine.

Data show higher risk for incident cancer observed with PCE of <7.2%, while higher PCE led to increased risk of incident CVD.

More studies are needed to determine whether bi-level positive airway pressure ventilation can help prevent acute chest syndrome.

Data from the large-scale, population-based study corroborate previous single-center study findings.

Results from the PREVENT-19 trial show the vaccine yields a 90% efficacy rate against symptomatic disease.

Data show variations in the type, effectiveness, and implementation of QI strategies for patients with CVD.

Suspected suicide attempts have increased more among females.

Opioid prescription decreased substantially in 2 years following 2016 CDC guideline for prescribing opioids for chronic pain.

Baseline eGFR and increasing age were good predictors of eGFR.

Sustained virologic response following direct acting antiviral treatment substantially reduced the all-cause mortality rate in patients with HCV.

The rate of major thromboembolism within 90 days was 1.2% for placebo and 1.0% for dalteparin.

A new Polish study calls for greater focus on asthma and the link to delirium in older patients, who may face greater mortality risk.

More than half of the patients in the study were treated for inflammatory bowel disease with infliximab.

A large number of nationwide infection rates in long-term care facilities are a product of seasonal influenza and RSV, according to a new study.

Researchers urge parents and doctors to take a closer look at the common disease and its possible more severe subtypes.

The expansion for sofosbuvir/velpatasvir is supported by phase 2 data showing an 83% sustained virologic response or cure rate among patients as young as 3 years old.

BUP associated with lower likelihood of any opioid use among participants with mood disorders, without mental disorder, compared to MET.

Patients included in the study had a median of 3 prior CDI episodes and 4 risk factors for recurrent infections.

Reported HRQOL remains consistent in youth with T1D, but multiple comorbidities and mental health conditions linked to decline.

Dapagliflozin and the SGLT2 inhibitor class may have untapped potential far beyond the reduction of heart failure hospitalization risk.

REL-1017 was more effective when administered earlier rather than later.

A systematic review of clinical trials notes that topical eye drops may lead to favorable retinal and visual outcomes, despite heterogeneity across multiple studies.

Data show 21.2% of patients with CAD reported angina at least once monthly, with 12.5% reporting daily or weekly angina.

Elexacaftor/tezacaftor/ivacaftor and ivacaftor was previously approved for CF patients at least 12 years old.

The UNITI studies have shown ustekinumab is effective at inducing and maintaining clinical remission in Crohn’s disease patients.

The COVID-19 pandemic had forced vitiligo patients to delay treatments; however, not much is known about the effects of delaying on disease course.